2015 Press Releases

Webcast ImageWebcast
Chromadex Corp at the 11th Annual LD Micro Main Event (Replay)
12/05/18 at 4:30 p.m. PT
Chromadex Corp at the 11th Annual LD Micro Main Event
Wednesday, December 5, 2018 4:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
12/17/15ChromaDex and American Laboratories Collaborate to Provide Identity Test for Glandular Related Ingredients
ChromaDex’s ComplyID™ Identity Testing Program to Help Dietary Supplement Companies Meet FDA Requirements IRVINE, Calif., Dec. 17, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC) and American Laboratories, Inc. (ALI) announced today the release of a Fourier Transform Near Infrared (FT-NIR) based identification method for the positive identification of desiccated bovine and porcine glandular tissues used in nutritional product formulations. ChromaDex has developed a FT-NIR algorithm a... 
Printer Friendly Version
11/24/15ChromaDex to Present at 27th Annual Piper Jaffray Healthcare Conference
IRVINE, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that its Chief Executive Officer and Founder, Frank Jaksch will present at the 27th Annual Piper Jaffray Healthcare Conference. The conference is being held on December 1-2, 2015 at the New Yo... 
Printer Friendly Version
11/23/15Jarrow Formulas Plans US Retail Launch of a Nicotinamide Riboside Product Featuring ChromaDex’s NIAGEN®
ChromaDex’s Patented Ingredient NIAGEN® is the World’s First and Only Commercially Available Form of Nicotinamide Riboside (NR) IRVINE, Calif., Nov. 23, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that Jarrow Formulas, a formulator and supplier of superior nut... 
Printer Friendly Version
11/18/15NIH and ChromaDex Announce Material Cooperative Research and Development Agreement to Study the Effects of ChromaDex’s NIAGEN® Nicotinamide Riboside on Cockayne Syndrome and Ataxia Telangiectasia
The National Institute on Aging Has Preliminary Research That Supports Further Testing of NR for Possible Beneficial Effects on Xeroderma Pigmentosum IRVINE, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today a Materials Cooperative Research and D... 
Printer Friendly Version
11/16/15ChromaDex Lead Ingredient NIAGEN® Nicotinamide Riboside Receives New Dietary Ingredient (NDI) Status From the FDA
IRVINE, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today it has received New Dietary Ingredient (NDI) status from the FDA for its patented and proprietary lead ingredient, NIAGEN® nicotinamide riboside. ChromaDex's NIAGEN® is the first and only c... 
Printer Friendly Version
11/12/15ChromaDex Reports 6th Consecutive Quarter of Record Revenue as Q3 Ingredients Sales Climb 104%
- Public Company Reaches GAAP Break-Even as 3rd Quarter Revenue Grows 52% to a Record $6.3 Million - IRVINE, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today record revenue for the third quarter ended October 3, 2015.  The report marks the sixth... 
Printer Friendly Version
11/05/15ChromaDex Enters Into an Exclusive Joint Development Agreement with The Procter & Gamble Company
IRVINE, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products is proud to announce it has entered into a joint development agreement with The Procter & Gamble Company (NYSE:PG) (“P&G”). Under the terms of the agreement, ChromaDex will provide P&G exclusi... 
Printer Friendly Version
11/05/15ChromaDex Announces $2,000,000 Registered Direct Offering
Financing Increases Stockholder Equity as Company Pursues an Uplisting to a National Exchange IRVINE, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today it has entered into an agreement with three of its largest existing shareholders - Dr. Philip ... 
Printer Friendly Version
11/03/15ChromaDex to Report Third Quarter 2015 Financial Results on Thursday, November 12, 2015
Company Will Host Investor Conference Call on Monday, November 16, 2015 IRVINE, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that it plans on reporting its third quarter 2015 financial results on Thursday, November 12, after the close of t... 
Printer Friendly Version
10/07/15ChromaDex Corp. Presentation Now Available for On-Demand Viewing
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation IRVINE, Calif., Oct. 7, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX: CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, today announced that the October 1 presentation from Frank Jaksch,... 
Printer Friendly Version
09/28/15ChromaDex Corp. to Webcast, Live, at VirtualInvestorConferences.com October 1
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com IRVINE, Calif., Sept. 28, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, today announced that Frank Jaksch, CEO and Founder, will pr... 
Printer Friendly Version
09/28/15ChromaDex to Webcast Live at VirtualInvestorConferences.com on October 1, 2015
Company Invites Institutional and Individual Investors to Attend Interactive Real-Time Virtual VirtualInvestorConferences.com IRVINE, Calif., Sept. 28, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today, that its Chief Executive Officer and Founder, Frank Jaksch will p... 
Printer Friendly Version
09/10/15ChromaDex to Present at The 6th Annual Craig-Hallum Alpha Select Conference on September 17, 2015
IRVINE, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today, that its Chief Executive Officer and Founder, Frank Jaksch will present at The 6th Annual Craig-Hallum Alpha Select Conference. The conference is being held on September 17, 2015 at the Covene... 
Printer Friendly Version
09/10/15ChromaDex Launches New Patented Ingredient - IMMULINA(TM) - a Powerful, Natural Ingredient That Boosts the Immune System
Dr. Loges' Immunloges(R) is First Product Launched Featuring ChromaDex's IMMULINA(TM) as the Main Active Ingredient IRVINE, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products is proud to announce the launch of IMMULINA™ to their family of branded ingredients. The add... 
Printer Friendly Version
09/09/15ChromaDex Announces Introduction of CVS Health NIAGEN(R) NR Age Defense Supplement
The New Dietary Supplement Formulated to Help Support Cognitive Endurance and Energy is Available in CVS Locations IRVINE, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today a new dietary supplement product, NIAGEN® NR Age Defense, is now available at ... 
Printer Friendly Version
08/18/15ChromaDex to Host Investor Call on Wednesday, August 19th at 11am EDT
IRVINE, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products will host an investor conference call to discuss the 2015 second quarter results and provide a general business update on Wednesday, August 19th, at 11am EDT. Participants should call in at least 10 minut... 
Printer Friendly Version
08/13/15ChromaDex Reports 5th Consecutive Quarter of Record Revenue as Q2 Ingredients Sales Climb 98%
Total 2nd Quarter Revenue Grew 58% to a Record $6.1 Million IRVINE, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today record revenue for the second quarter ended July 4, 2015. The report marks the fifth consecutive quarter of record revenues for the... 
Printer Friendly Version
08/12/15Results from First Human Clinical Study Demonstrate ChromaDex's NIAGEN(R) Nicotinamide Riboside Effectively Increases the Co-enzyme NAD+ and is Safe
- Clinical Data Presented Today at the FASEB Science Research Conference on NAD+ Metabolism and Signaling - IRVINE, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that results of the first controlled human clinical study on the use of the Co... 
Printer Friendly Version
08/12/15ChromaDex and Collaborators Report Unexpected Discovery of Novel Biomarkers of Effective NAD+ Precursor, Nicotinamide Riboside
Unexpected Results in the First Human Clinical Study of the Company's NIAGEN(R) (Nicotinamide Riboside) Led to the Filing of a Provisional Patent on the Discovery IRVINE, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced that ChromaDex Scientific Advisor... 
Printer Friendly Version
08/06/15ChromaDex to Report Second Quarter 2015 Financial Results on Thursday, August 13, 2015
Company Will Host Investor Conference Call on Wednesday, August 19, 2015 IRVINE, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that it plans on reporting its second quarter 2015 financial results on Thursday, August 13, after the close of the fi... 
Printer Friendly Version
07/29/15Nutrition Business Journal Honors ChromaDex With Business Achievement Award for Growth
ChromaDex Has Reported Four Consecutive Quarters of Record Net Revenue and Receives Accolades for Top Growth Company in the $10-$50 Million Annual Sales Category IRVINE, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today it has received the 2014 NBJ ... 
Printer Friendly Version
07/28/15Alsa, Featuring PURENERGY(R), Provides Sustained Energy Boost and Mental Alertness Without the Jolt of the Typical Energy Drink
IRVINE, Calif., July 28, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, and Sync Health Solutions, innovators of products and companies within the health and wellness industry, announced the launch of Sync Health Solutions' new branded lifestyle energy product, Älsa™. The energy burst from Älsa™ is derived from ChromaDex's patented PURENERGY®. By dissolving a single-dose Älsa packet in 16 ounces of water, the v... 
Printer Friendly Version
07/13/15ChromaDex Welcomes Business & Media Executive and Academy Award Winning Producer, Rob Fried, to Its Board of Directors
IRVINE, Calif., July 13, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that Rob Fried has joined the Company's Board of Directors as an Independent Director. Mr. Fried, age 56, served as Chairman of the Board of Directors of IDI, Inc. (NYSE MKT:IDI) (formerly T... 
Printer Friendly Version
06/18/15ChromaDex Announces a Collaborative Human Clinical Study on NIAGEN(R) With the University of Colorado Boulder
- The Integrative Physiology of Aging Laboratory, Headed by Dr. Douglas Seals, Will Investigate the Effects of NIAGEN® on Physical Function and Metabolism in Healthy Adults Aged 45-79 Years - IRVINE, Calif., June 18, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced toda... 
Printer Friendly Version
06/04/15ChromaDex Expands Patent Rights to Pterostilbene
IRVINE, Calif., June 4, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today it has added to its list of exclusive patents rights related to pterostilbene licensed from the University of Mississippi. The newly licensed patent relates to potential anti-obesity effects of pterostilbene. C... 
Printer Friendly Version
06/02/15Healthy Directions has Launched NRG AdvantageTM Featuring NIAGEN(R)-the World's First and Only Commercially Available Form of Nicotinamide Riboside (NR)
The New Dietary Supplement Protects Against Oxidative Stress and Promotes Healthy Aging IRVINE, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), creators of innovative proprietary-based solutions that impact dietary supplement, food and beverage, cosmetic, and pharmaceutical products is pleased to announce that Healthy Directions, a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited (Nasdaq:HELE) is launching a new dieta... 
Printer Friendly Version
05/21/15ChromaDex Announces Exclusive Worldwide License and Supply Agreement for Anthocyanin Rich Suntava(R) Purple Corn
ChromaDex Will Use Proprietary Suntava(R) Purple Corn to Produce a Highly Concentrated Anthocyanin Ingredient at a Price Point That Should Appeal to Mass Markets IRVINE, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today it has entered into an exclusive worldwide license ... 
Printer Friendly Version
05/20/15ChromaDex to Present at the LD Micro Invitational Conference on June 2, 2015
IRVINE, Calif., May 20, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the LD Micro Invitational Conference. The conference is being held on June 1 - 3, 2015 at the Luxe Sunset Bel Air Hotel in Los Angeles. Mr. Jaksch is ... 
Printer Friendly Version
05/18/15ChromaDex to Present at the 2015 Marcum MicroCap Conference on May 28, 2015
IRVINE, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 2015 Marcum MicroCap Conference. The conference is being held on May 27 to 28, 2015 at The Grand Hyatt Hotel in New York City. Mr. Jaksch is sched... 
Printer Friendly Version
05/14/15ChromaDex Reports 1st Quarter Record Revenue as Ingredients Sales Soar 136%
- Total Q1 Revenue Grew 71% to $5.3 Million as Company Reports 4th Consecutive Quarter of Record Net Revenue - IRVINE, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today record revenue for the first quarter ended April 4, 2015. The report marks the fourth consecutive qua... 
Printer Friendly Version
05/11/15ChromaDex to Host First Quarter 2015 Investor Call on Monday, May 18th at 11 am EDT
Company Will Release First Quarter Earnings Report After Market Close on May 14th IRVINE, Calif., May 11, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, plans to report its first quarter 2015 financial results on Thursday, May 14, after the close of the financial markets. ChromaDex management w... 
Printer Friendly Version
04/29/15Washington University Medical School Scientists Publish Results of Pre-Clinical Study Showing Nicotinamide Riboside is Effective in Rescuing Neurons Subjected to Trauma and Disease
- Study Showed Axon Degeneration and Cell Death are Blocked by Supplementation with the Cell-permeable NAD+ Precursor, Nicotinamide Riboside - - A Recent Scripps Study Also Showed Restoring levels of NAD+ Reversed Within Only a Few Hours the Fate of Neurons That Had Been Doomed to Destruction - IRVINE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the d... 
Printer Friendly Version
04/20/15ChromaDex Appoints Former GlaxoSmithKline Executive, Jeff Baxter, to Its Board of Directors
IRVINE, Calif., April 20, 2015 (GLOBE NEWSWIRE) -- ChromaDex Corp. (OTCQX:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that Jeff Baxter has joined the Company's Board of Directors as an Independent Director. Mr. Baxter, age 53, has served as President and CEO and a Director of VBI Vaccines, Inc. (Nasdaq:VBIV) since 2009. Prev... 
Printer Friendly Version
04/10/15Published Study Shows Topical Treatment With Pterostilbene Effectively Protects Hairless Mice Against UVB Radiation-Induced Skin Damage and Carcinogenesis
ChromaDex Holds Exclusive Worldwide Patent Rights Related to Pharmaceutical and Cosmetic Preparations of Pterostilbene for Topical Application IRVINE, Calif., April 10, 2015 (GLOBE NEWSWIRE) -- A study recently published on April 3, 2015 in Free Radical Biology and Medicine showed pterostilbene prevented acute ultraviolet B radiation ("UVB"), radiation-induced inflammation and photoaging-associated skin damages. The study further showed that pterostilbene, but not resveratrol, effectively preve... 
Printer Friendly Version
03/19/15ChromaDex® Reports 2014 Ingredient Sales Grew 182%
- Total Revenue Increased 51% in 2014 - IRVINE, Calif., March 19, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today the financial results for the year ended January 3, 2015. For the year ended January 3, 2015 ("FY 2014"), ChromaDex reported net sales of $15.3 million, an increase of... 
Printer Friendly Version
03/05/15ChromaDex to Present at the Northland Capital Markets 2015 Growth Conference on March 18, 2015
IRVINE, Calif., March 5, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the Northland Capital Markets 2015 Growth Conference. The conference will be held on March 18, 2015 at the Omni Berkshire Place Hotel in New York City. M... 
Printer Friendly Version
03/03/15ChromaDex® Appoints Former Nestle Executive, Steve Allen, as Chairman
- Company Reduces Number of Directors from Nine to Seven - IRVINE, Calif., March 3, 2015 /PRNewswire/ -- ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today the appointment of Steve Allen as the Chairman of its Board. Allen, age 65, joined the Company's Board as an independent director in January 2014. ... 
Printer Friendly Version
02/18/15ChromaDex® to Present at the 27th Annual ROTH Conference on March 10, 2015
- CEO's presentation will be webcast live at 8:00 PDT / 11:00 am EDT - IRVINE, Calif., Feb. 18, 2015 /PRNewswire/ -- ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 27th Annual ROTH Conference. The conference is being held on March 8-11, 2015 at The Ritz-C... 
Printer Friendly Version
02/11/15ChromaDex's NIAGEN™ Nicotinamide Riboside Meets Primary Endpoint in First Human Clinical Study
- Results Confirm That NR Increases the Mitochondrial Co-enzyme NAD+ and is Safe - - Full Study Results to be Peer Reviewed for Scientific Publication - IRVINE, Calif., Feb. 11, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX: CDXC) announced today that the initial results of the first human clinical study for the company's NIAGEN® nicotinamide riboside (NR) has met its primary endpoint. The results demonstrated that a single dose of NR resulted in statistically significant increases in the ... 
Printer Friendly Version
02/05/15Sports Nutrition Supplier BPI Sports Adopts ChromaDex® Quality Verification Seal Program
IRVINE, Calif., Feb. 5, 2015 /PRNewswire/ -- ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that sports nutrition supplier BPI Sports has contracted with ChromaDex for third-party verification of BPI Sports' protein products. Going forward, the "ChromaDex® Quality Verified Seal" will be added to the entir... 
Printer Friendly Version
01/06/15ChromaDex® CEO to Present at The Sidoti & Company, LLC Emerging Growth Institutional Investor Forum on January 12th
IRVINE, Calif., Jan. 6, 2015 /PRNewswire/ -- ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at The Sidoti & Company, LLC's Emerging Growth Institutional Investor Forum on Monday, Jan. 12, 2015 at The Grand Hyatt Hotel in New York City. Mr. Jaks... 
Printer Friendly Version